87694-58-4 Usage
Uses
Used in Pharmaceutical Industry:
PYR-TRP-OET is used as a compound in drug development for its potential therapeutic applications in various medical conditions. Its unique combination of components allows for the exploration of its effects on different biological systems, making it a valuable asset in the search for novel treatments.
Used in Biochemical Research:
In the field of biochemistry, PYR-TRP-OET serves as a subject of interest for research. Its distinct properties and interactions with biological molecules can provide insights into various biochemical processes and contribute to the understanding of complex biological systems.
Used in Cancer Treatment:
PYR-TRP-OET is being studied for its potential as an anticancer agent. Its unique composition may offer new avenues for the development of targeted therapies, potentially leading to more effective treatments for various types of cancer.
Used in Neurological Disorders Research:
PYR-TRP-OET's potential applications extend to the field of neurological disorders. Its presence in biochemical and pharmaceutical research allows for the investigation of its effects on neurological conditions, potentially leading to the development of new treatments for disorders affecting the brain and nervous system.
Check Digit Verification of cas no
The CAS Registry Mumber 87694-58-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,6,9 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 87694-58:
(7*8)+(6*7)+(5*6)+(4*9)+(3*4)+(2*5)+(1*8)=194
194 % 10 = 4
So 87694-58-4 is a valid CAS Registry Number.
87694-58-4Relevant academic research and scientific papers
Synthesis, characterization and in vitro hydrolysis of L-pyroglutamyl-L-tryptophan derivatives as potential drug carriers
Bousquet,De Regis,Giannola,Santagati,Tirendi
, p. 260 - 262 (2007/10/02)
The condensation reaction of L-tryptophan with L-pyroglutamic acid or its N-carbobenzyloxy derivative in the presence of dicyclohexylcarbodiimide (DCC) afforded dipeptide molecules identified as L-pyroglutamyl-L-tryptophan derivatives. The synthesized dipeptide molecules offer a potentially useful means to obtain drug carriers and improve the poor uptake of drug molecules to the brain. The chemical hydrolysis characteristics in simulated gastro-intestinal juices are reported. No significant hydrolysis was observed.
